Richard C. Cilento Jr. - 24 Jan 2024 Form 3/A Insider Report for FibroBiologics, Inc. (FBLG)

Role
Director
Signature
/s/ Mark Andersen, by Power of Attorney
Issuer symbol
FBLG
Transactions as of
24 Jan 2024
Net transactions value
$0
Form type
3/A
Filing time
13 Aug 2024, 16:01:21 UTC
Date Of Original Report
07 Feb 2024
Next filing
27 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding FBLG Stock Option (Right to Buy) 24 Jan 2024 Common Stock 185,300 $2.28 Direct F1
holding FBLG Stock Option (Right to Buy) 24 Jan 2024 Common Stock 5,000 $3.28 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1/4 of the options vested on January 1, 2024, with the remainder vesting monthly over 36 months.
F2 All options vested on September 26, 2023, the one-year anniversary of the date of grant.

Remarks:

This amendment is filed to include stock options in Table II that were inadvertently omitted in the original filing.